Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines
Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma
Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo
Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70
Immunization with antigen-pulsed dendritic cells significantly improves the immune response to weak self-antigens
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection
Dendritic cell defects in patients with cancer: mechanisms and significance
Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
Genetically modified dendritic cells for therapeutic immunity
Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination
Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma
Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model
From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy
Immunity to melanoma antigens: from self-tolerance to immunotherapy
Vaccine efficacy of fusogenic liposomes containing tumor cell-lysate against murine B16BL6 melanoma
Immunotherapy for prostate cancer
Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma